Strong immunogenicity profile observed in study participants aged 5-17 years one month after the primary vaccination series Safety profile observed in pediatric participants similar to previously reported data in adult participants Pediatric population to be ...
Ontario’s top public health official has released a statement reiterating his belief in the safety and effectiveness of Pfizer’s pediatric vaccine after facing criticism for previous statements that appeared to question whether there was enough ...
Ontario’s top public health official has released a statement reiterating his belief in the safety and effectiveness of Pfizer’s pediatric vaccine after facing criticism for previous statements that appeared to question whether there was enough ...
1 INTRODUCTION Pneumonia is a form of acute respiratory infection that is most commonly caused by viruses or bacteria, accounting for 15% of all deaths of children under 5 years of age worldwide.1 Recently an ...
